Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.50 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.50 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.50 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.50 |
| ▸ | FAP | Q12884 | 1/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | MME | P08473 | 3/20 | 0.42 |
| ▸ | PDCD1LG2 | Q9BQ51 | 2/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | VSIR | Q9H7M9 | 1/20 | 0.35 |
| ▸ | CTSC | P53634 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3402324 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL31174307 | 1.00 | DPP4 (0.50) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL30353290 | 0.94 | DPP4 (0.46) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7218621 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5579160 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL5579158 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7218624 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL31174304 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL27663801 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL10803670 | 0.90 | MME (0.43) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-105683390-B | HbA1c measurement method using amadoriase acting on glycosylated peptide | 龟甲万株式会社 | 2021-02-26 | — | — | CN | disclosed |
| CN-106455664-A | Composition with high content of cyclic dipeptide | 三得利控股株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-106456633-A | Sugar metabolism improving agent | 三得利控股株式会社 | 2017-02-22 | — | — | CN | disclosed |
| EP-2248821-B1 | SUBSTRATE FOR ASSAYING -GLUCAN AND/OR ENDOTOXIN AND ASSAY METHOD | WAKO PURE CHEM IND LTD (JP) | 2015-01-28 | — | — | EP | disclosed |
| US-8546072-B2 | Substrate for assaying β-glucan and/or endotoxin and assay method | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-20100330700-A1 | SUBSTRATE FOR ASSAYING BETA-GLUCAN AND/OR ENDOTOXIN AND ASSAY METHOD | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-30 | — | — | US | disclosed |
| EP-2248821-A1 | SUBSTRATE FOR ASSAYING -GLUCAN AND/OR ENDOTOXIN AND ASSAY METHOD | Wako Pure Chemical Industries, Ltd. (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-0885899-A1 | Method for obtaining peptide fragments by use of fluorinated organic acids | SEIKO INSTRUMENTS INC. (JP) | 1998-12-23 | — | — | EP | disclosed |